A cyclist was killed early Thursday morning in an Aurora crash, and police are investigating alcohol as a potential factor, according to the department.
The cyclist was crossing South Havana Street in the 700 block at about 1:55 a.m. Thursday, according to a news release from the Aurora Police Department.
He was outside of the crosswalk when he was hit by a GMC Yukon driving north on Havana, police said in the release.
The cyclist, who died from his injuries at the scene of the crash, will be identified by the Arapahoe County Coroner’s Office.
Investigators believe both speed and alcohol were factors in the crash, police said.
Related Articles
Fatal shuttle bus crash prompts traffic light changes at Commerce City intersection Motorcyclist injured in Denver hit-and-run on I-25, under I-70 overpass 72-year-old pedestrian struck and killed by driver in Aurora Elkhorn fire near Durango grows, evacuations lifted for Rim Road wildfire in southwestern Colorado Teen’s legs slashed by boat propeller while tubing at Cherry Creek ReservoirCharges against the unidentified driver are “pending investigation,” police said. None had been filed as of Thursday morning.
This is a developing story and may be updated.
Sign up to get crime news sent straight to your inbox each day.
Hence then, the article about aurora cyclist killed in suspected dui crash on havana was published today ( ) and is available on The Denver Post ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Aurora cyclist killed in suspected DUI crash on Havana )
Also on site :
- Ukraine-Russia war latest: Zelensky awaits Putin response to new peace plan while Christmas Eve blast kills 3 in Moscow
- JCPenney Has a 'Stunning' White Sapphire Jewelry Set on Sale for Just $16, and It's Perfect for Every Occasion
- China's First Domestic Anti-CTLA-4 Monoclonal Antibody, Innovent's TABOSUN® (Ipilimumab N01 Injection) Received NMPA Approval